Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Acute Lymphoid Leukemia (ALL): early-phase trial registry

1 of 2 indexed Acute Lymphoid Leukemia (ALL) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Acute Lymphoid Leukemia (ALL): 2 US clinical trials tracked, 1 recruiting.

Acute Lymphoid Leukemia (ALL) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Center for International Blood and Marrow Transplant Research, running 1 of these trials.

Enrollment posture brief

Registry condition acute-lymphoid-leukemia-all

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Acute Lymphoid Leukemia (thi…50%
Open-enrollment share among volume-matched conditions near Acute Lymphoid Leukemia (ALL)

Acute Lymphoid Leukemia (ALL) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Lymphoid Leukemia (ALL) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Lymphoid Leukemia (ALL) is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on Acute Lymphoid Leukemia (ALL) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GCSF Drug
1 trials
Hyper fractionated total body irradiation Radiation
1 trials
Personalized rATG (P-rATG) Other
1 trials
Conditioning Regimen E Drug
1 trials
Conditioning Regimen D Drug
1 trials
Conditioning Regimen C Drug
1 trials
Conditioning Regimen B Drug
1 trials
Conditioning Regimen A Drug
1 trials

US sites by state

Facility locations filed on Acute Lymphoid Leukemia (ALL) trials. A trial with sites in several states counts in each.

New York 2 trials
Washington 1 trials
Virginia 1 trials
Texas 1 trials
Oregon 1 trials
North Carolina 1 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Lymphoid Leukemia (ALL) page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Lymphoid Leukemia (ALL) condition card totals 2 registered trials; most-linked intervention GCSF; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.